Skill Profile
Drug Interaction Screening
"The observable action of reviewing a patient's full medication list against known drug-drug and drug-disease interaction databases in order to identify and resolve combinations that could cause adverse effects or reduce therapeutic efficacy."
YOUR SKILLS
Problems This Skill Solves
- Adverse drug reactions caused by prescribed combinations that interact — such as warfarin and NSAIDs increasing bleeding risk — which are largely preventable with systematic screening
- Therapeutic failure caused by drug interactions that reduce plasma levels of critical medications, such as rifampicin inducing CYP450 enzymes and reducing efficacy of many co-prescribed drugs
- Polypharmacy-related harm in elderly patients, where five or more medications create a complex interaction matrix that no individual clinician holds in memory
- Dangerous QT prolongation caused by combinations of drugs that affect cardiac conduction independently but additively
Tools Used
Roles That Use This Skill
1 total · 1 industryThis skill is concentrated in one industry.
Healthcare / Retail / NHS
"Electronic prescribing systems will catch all dangerous drug interactions automatically."
Electronic prescribing alerts catch many known interactions, but they generate a high volume of low-severity alerts that leads to alert fatigue — clinicians learn to dismiss them without reading. Critical interactions are routinely overridden. Additionally, systems do not always screen for drug-disease interactions, drug-food interactions (e.g. grapefruit and statins), or OTC and herbal medicines the patient has not disclosed. Skilled clinical review remains essential because automated systems are a safety net, not a substitute for pharmacological knowledge and clinical judgement.
Research & Outlook
Drug interaction screening is increasing in importance as polypharmacy rises with an ageing population and multi-morbidity. Clinical pharmacists embedded in GP practices, ward-based clinical pharmacy, and structured medication review programmes are expanding the professional scope of interaction screening beyond dispensing into active clinical decision support. AI-assisted clinical decision support tools are improving alert specificity, reducing fatigue and improving uptake of genuine warnings — but human pharmacological expertise remains essential for complex or novel interaction scenarios.
See This Skill In Action
Watch a professional demonstrate Drug Interaction Screening in a real working environment — what it looks like, how it's applied, and why it matters.
Clinical / Healthcare
Drug Interaction Screening
Also Known As
Growth Path
Can use the BNF interactions appendix and electronic prescribing alerts to identify flagged drug interactions for a patient on straightforward polypharmacy. Understands the severity categories (contraindicated, major, moderate, minor) and escalates significant interactions to the responsible prescriber.
Reviews medication lists for complex patients systematically, cross-referencing multiple interaction databases and applying clinical judgement to determine whether an interaction requires action, monitoring, or dose adjustment. Understands CYP450 enzyme induction and inhibition mechanisms and can anticipate interactions for newly introduced medications.
Leads medicines optimisation reviews for high-risk patient groups (oncology, elderly care, HIV, transplant), managing interaction matrices involving ten or more concurrent medications. Advises prescribers on interaction management strategies, contributes to formulary decisions, and trains junior pharmacists in systematic interaction screening methodology.
How to Practise
- 1.Review the BNF interactions appendix for a sample patient with five or more medications and identify all clinically significant interactions by severity category.
- 2.Complete a medicines reconciliation for a complex patient admission — list all pre-admission medications, hospital prescriptions, and OTC drugs, then screen systematically for interactions.
- 3.Use an online CYP450 interaction checker to map the metabolic pathways of a set of commonly co-prescribed drugs and identify which combinations require dose adjustment.
- 4.Review clinical case studies of interaction-related adverse events (available in pharmacy training resources and the Yellow Card scheme database) to understand real-world consequences.
How to Prove
- ·GPhC registration with clinical pharmacy competency record demonstrating medicines review experience
- ·Documented medicines reconciliation completed on hospital admission for complex polypharmacy patients, with interactions identified and acted upon
- ·Clinical interventions log showing drug interaction queries raised with prescribers, with outcomes recorded
- ·Completion of a structured medication review programme such as STOPP/START or PINCER in primary care